论文部分内容阅读
恶性胸液为肿瘤组织侵犯胸膜所致,我们应用白介素-2(IL-2)胸腔注射治疗16例,收到良好的效果,总结如下。 1 临床资料 1.1 一般资料 16例中男7例,女9例;年龄29~78岁,平均年龄53岁。其中肺癌10例,淋巴瘤3例,多发性骨髓瘤2例,乳腺癌胸腔转移1例。肺癌10例中,2例鳞癌,8例腺癌。所有患者胸液中均找到癌细胞。治疗前大量胸液12例,中等量胸液2例,少量胸液1例。13例胸液呈血性或洗肉水样。所有患者均有不同程度的咳嗽、心慌、气促、神萎、食欲减退等临床症状。
Malignant pleural effusion was caused by tumor tissue invading the pleura. We used interleukin-2 (IL-2) intrapleural injection for treatment in 16 cases and received good results, summarized as follows. 1 clinical data 1.1 General Information 16 cases of 7 males and 9 females; aged 29 to 78 years, mean age 53 years. There were 10 cases of lung cancer, 3 cases of lymphoma, 2 cases of multiple myeloma, and 1 case of thoracic metastasis of breast cancer. Of the 10 lung cancer cases, 2 were squamous cell carcinoma and 8 were adenocarcinoma. Cancer cells were found in the pleural fluid of all patients. A large number of pleural fluids were treated before treatment in 12 cases, moderate pleural fluid in 2 cases, and a small amount of pleural fluid in 1 case. 13 cases of pleural bloody or wash water samples. All patients have different degrees of cough, palpitation, shortness of breath, Shen Wei, loss of appetite and other clinical symptoms.